Jun 11, 2020
Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19
Jun 07, 2020
CORRECTED: Liberia set to ease virus restrictions
May 13, 2020
BARDA Provides the Sabin Vaccine Institute With an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines
Apr 16, 2020
FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola
Apr 08, 2020
BGI Unveils Huo-Yan Air Lab Rapid Deployment Inflatable Biosafety Laboratory for Fast and Effective COVID-19 In-country Testing
Apr 02, 2020
Breakthrough Ebola Treatment Receives Contract from U.S. Government
Mar 26, 2020
Cory Chalmers, CEO of Steri-Clean, Provides Guidelines for Proper Disinfection During COVID-19 Pandemic
Mar 19, 2020
Canon Medical to Commence Development of a Rapid Genetic Testing System for Novel Coronavirus (COVID-19)
Mar 19, 2020
Sierra Leone to suspend international flights over coronavirus
Mar 10, 2020
Virus death toll soars in locked-down Italy as pace slows in China
Mar 04, 2020
Lutheran World Relief and IMA World Health prepare for coronavirus in Africa
Feb 27, 2020
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform
Feb 04, 2020
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus
Dec 19, 2019
First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
Dec 08, 2019
Johnson & Johnson Announces Commitment to Support Republic of Rwanda's Preparedness Against Ebola Outbreak
Nov 28, 2019
Ridgeback Biotherapeutics LP announces publication of mAb114 results in the New England Journal of Medicine
Oct 31, 2019
Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
Oct 10, 2019
FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens
Sep 06, 2019
Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb114
Aug 12, 2019
Ridgeback Biotherapeutics LP announces an update on mAb114, an experimental treatment for Ebola